Marco Vacante Selected Research

Acetylcarnitine (Alcar)

5/2014	Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial.
12/2011	Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
9/2011	The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin.
6/2011	Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.
4/2011	Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.
11/2008	Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
3/2008	Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Vacante Research Topics

Disease

7	Chronic Hepatitis C 11/2016 - 04/2008
5	Neoplasms (Cancer) 08/2020 - 07/2011
5	Hepatic Encephalopathy 08/2015 - 11/2008
5	Viremia 01/2015 - 02/2011
5	Fatigue 05/2014 - 12/2007
5	Type 2 Diabetes Mellitus (MODY) 01/2013 - 01/2009
4	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 12/2018
3	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2011
3	Fibrosis (Cirrhosis) 08/2015 - 07/2010
3	Chronic Hepatitis (Chronic Active Hepatitis) 01/2015 - 07/2010
3	Hepatocellular Carcinoma (Hepatoma) 12/2014 - 07/2010
3	Mental Fatigue 05/2014 - 12/2007
2	Colonic Neoplasms (Colon Cancer) 06/2022 - 12/2021
2	Carcinoma (Carcinomatosis) 06/2021 - 11/2020
2	Adenoma (Adenomas) 06/2021 - 11/2020
2	Infections 04/2021 - 11/2016
2	Carcinogenesis 04/2021 - 12/2018
2	Frailty 03/2020 - 01/2013
2	Inflammation (Inflammations) 12/2018 - 01/2010
2	Atherosclerosis 01/2013 - 01/2010
2	Hepatitis C 09/2011 - 04/2008
2	Hypertension (High Blood Pressure) 07/2011 - 10/2010
2	Non-alcoholic Fatty Liver Disease 02/2011 - 06/2010
2	Muscular Diseases (Myopathy) 10/2010 - 01/2009
2	Myalgia 10/2010 - 01/2009
1	Anastomotic Leak 12/2021
1	Surgical Wound Infection 12/2021
1	Rectal Neoplasms (Rectal Cancer) 01/2021
1	Residual Neoplasm 08/2020
1	Circulating Neoplastic Cells 08/2020
1	Cognitive Dysfunction 09/2019
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 01/2019
1	Hypothyroidism 01/2019
1	Microsatellite Instability 12/2018
1	Postoperative Pain 01/2016
1	Wound Infection (Wound Infections) 01/2016
1	Weight Loss (Weight Reduction) 12/2015
1	Coma (Comas) 08/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2015

Drug/Important Bio-Agent (IBA)

7	Ribavirin (Virazole)FDA LinkGeneric 11/2016 - 04/2008
7	Acetylcarnitine (Alcar)IBA 05/2014 - 03/2008
7	Carnitine (L-Carnitine)FDA LinkGeneric 10/2011 - 12/2007
5	InterferonsIBA 11/2016 - 02/2011
4	Biomarkers (Surrogate Marker)IBA 08/2020 - 07/2010
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2014 - 09/2011
4	Alanine Transaminase (SGPT)IBA 05/2014 - 09/2011
3	Lipoprotein(a)IBA 01/2013 - 08/2009
3	CholesterolIBA 02/2012 - 01/2009
3	Glucose (Dextrose)FDA LinkGeneric 02/2012 - 01/2010
3	Simvastatin (Zocor)FDA LinkGeneric 11/2009 - 01/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 06/2021
2	EnzymesIBA 09/2019 - 02/2011
2	Vitamin E FDA LinkGeneric 11/2016 - 01/2015
2	Phospholipids (Phosphatides)FDA LinkGeneric 11/2016 - 01/2015
2	Silybin (Lagosa)IBA 11/2016 - 01/2015
2	AmmoniaIBA 08/2015 - 12/2011
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2015 - 01/2010
2	Biological ProductsIBA 01/2013 - 04/2011
2	BilirubinIBA 02/2012 - 10/2011
2	Triglycerides (Triacylglycerol)IBA 02/2012 - 02/2011
2	Insulin (Novolin)FDA Link 02/2012 - 02/2011
2	LDL Lipoproteins (beta Lipoproteins)IBA 02/2012 - 11/2009
2	LDL CholesterolIBA 02/2012 - 02/2011
2	Chromogranin AIBA 01/2012 - 07/2010
2	Uric Acid (Urate)IBA 07/2011 - 04/2009
2	Rosuvastatin Calcium (Crestor)FDA Link 02/2011 - 10/2010
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2010 - 01/2009
2	oxidized low density lipoproteinIBA 11/2009 - 01/2009
1	PrebioticsIBA 06/2021
1	Mitogen-Activated Protein KinasesIBA 04/2021
1	Calcibiotic Root Canal SealerIBA 11/2020
1	MicroRNAs (MicroRNA)IBA 08/2020
1	Proteins (Proteins, Gene)FDA Link 08/2020
1	Circulating Tumor DNAIBA 08/2020
1	Dipeptidyl-Peptidase IV InhibitorsIBA 09/2019
1	VildagliptinIBA 09/2019
1	IodineIBA 01/2019
1	Olive OilIBA 12/2018
1	Free RadicalsIBA 12/2018
1	Fluorouracil (Carac)FDA LinkGeneric 12/2018
1	gamma-Aminobutyric Acid (GABA)IBA 08/2015
1	Diazepam Binding InhibitorIBA 08/2015
1	Collagen Type III (Type III Collagen)IBA 01/2015
1	Matrix Metalloproteinases (MMPs)IBA 01/2015
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2015
1	Peptides (Polypeptides)IBA 01/2015
1	Hyaluronic Acid (Hyaluronan)IBA 01/2015

Therapy/Procedure

5	Therapeutics 03/2020 - 01/2009
2	Colectomy 06/2022 - 12/2021
2	Drug Therapy (Chemotherapy) 08/2020 - 07/2011
2	Operative Time 01/2016 - 12/2015
2	Oral Administration 01/2009 - 12/2007
1	Antibiotic Prophylaxis 12/2021
1	Adjuvant Chemotherapy 01/2021
1	Neoadjuvant Therapy 01/2021
1	Polypharmacy 03/2020
1	Mediterranean Diet 12/2018
1	Appendectomy 01/2016
1	Length of Stay 01/2016
1	Analgesia 01/2016